Georgi Tosev, Evgeniya Vladeva & Ivaylo Dimov. (2023) МODERN NON-INVASIVE METHODS FOR TREATING PEYRONIE'S DISEASE. World Science:1(79).
Crossref
Fabrizio Palumbo, Francesco Sebastiani, Alessandro Procacci, Nicola D’Altilia, Anna Ricapito & Luigi Cormio. 2023. Practical Clinical Andrology. Practical Clinical Andrology
61
73
.
Sulaiman Hayat, Oliver Brunckhorst, Hussain M Alnajjar, Onur Omer Cakir, Asif Muneer & Kamran Ahmed. (2022) A systematic review of non-surgical management in Peyronieʼs disease. International Journal of Impotence Research.
Crossref
Guo Nan Yin, Shuguang Piao, Zhiyong Liu, Lei Wang, Jiyeon Ock, Mi-Hye Kwon, Do-Kyun Kim, Yong Song Gho, Jun-Kyu Suh & Ji-Kan Ryu. (2021) RNA-sequencing profiling analysis of pericyte-derived extracellular vesicle–mimetic nanovesicles-regulated genes in primary cultured fibroblasts from normal and Peyronie’s disease penile tunica albuginea. BMC Urology 21:1.
Crossref
X. Rod, W. Akakpo & M. Roupret. (2021) Efficacité et tolérance des traitements locaux en injections pour le traitement de la maladie de La Peyronie : revue de la littérature. Progrès en Urologie 31:16, pages 1072-1079.
Crossref
David Čapka & Robert Grill. (2021) Peyronie's disease - today's treatment options. Urologie pro praxi 22:3, pages 143-147.
Crossref
Edward J. Choi, Perry Xu, Farouk M. El-Khatib & Faysal A. Yafi. (2021) Intralesional Injection Therapy and Atypical Peyronie's Disease: A Systematic Review. Sexual Medicine Reviews 9:3, pages 434-444.
Crossref
Ahmed I. El‐Sakka. (2020) Medical, non‐invasive, and minimally invasive treatment for Peyronie’s disease: A systematic review. Andrology 9:2, pages 511-528.
Crossref
Madeleine G. Manka, Lindsay A. White, Faysal A. Yafi, John P. Mulhall, Laurence A. Levine & Matthew J. Ziegelmann. (2021) Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. The Journal of Sexual Medicine 18:2, pages 363-375.
Crossref
Ayad Yousif, Caleb Natale & Wayne J. G. Hellstrom. (2021) Conservative Therapy for Peyronie’s Disease: a Contemporary Review of the Literature. Current Urology Reports 22:2.
Crossref
Jesse Ory, Landan MacDonald & Gavin Langille. (2020) Noninvasive Treatment Options for Peyronie’s Disease. Sexual Medicine Reviews 8:4, pages 603-614.
Crossref
Matthew J Ziegelmann, Petar Bajic & Laurence A Levine. (2020) Peyronie’s disease: Contemporary evaluation and management. International Journal of Urology 27:6, pages 504-516.
Crossref
U. Milenkovic & M. Albersen. 2020. Peyronie's Disease: Pathophysiology and Treatment. Peyronie's Disease: Pathophysiology and Treatment
91
103
.
Julian Marcon & Christian G. Stief. 2020. Urologic Principles and Practice. Urologic Principles and Practice
357
392
.
Matthew J. Ziegelmann, Landon W. Trost & Laurence A. Levine. 2020. Textbook of Male Genitourethral Reconstruction. Textbook of Male Genitourethral Reconstruction
467
481
.
Dyvon T. Walker, Arash Amighi, Steven A. Mills, Sriram V. Eleswarapu & Jesse N. Mills. (2019) Management of the Acute Phase of Peyronie’s Disease: a Contemporary Review. Current Sexual Health Reports 11:4, pages 370-380.
Crossref
Uros Milenkovic, Marcus M. Ilg, Selim Cellek & Maarten Albersen. (2019) Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie’s Disease. Sexual Medicine Reviews 7:4, pages 679-689.
Crossref
Peter Tsambarlis & Laurence A. Levine. (2018) Nonsurgical management of Peyronie’s disease. Nature Reviews Urology 16:3, pages 172-186.
Crossref
Karen Randhawa & C. J. Shukla. (2019) Non-invasive treatment in the management of Peyronie’s disease. Therapeutic Advances in Urology 11, pages 175628721882367.
Crossref
Edward Capoccia & Laurence A. Levine. (2018) Contemporary Review of Peyronie’s Disease Treatment. Current Urology Reports 19:7.
Crossref
Marek Broul, Petra Hokůvová & Jan Schraml. (2018) Experience with administration of verapamil into the plaque in patients with induratio penis plastica (Peyronie's disease). Urologie pro praxi 19:1, pages 29-32.
Crossref
Ali Can Albaz & Oktay Üçer. (2017) Peyronie’s Disease: Recent Treatment Modalities. European Medical Journal, pages 63-70.
Crossref
Faysal A. Yafi, Georgios Hatzichristodoulou, Kenneth J. DeLay & Wayne J.G. Hellstrom. (2017) Review of Management Options for Patients With Atypical Peyronie's Disease. Sexual Medicine Reviews 5:2, pages 211-221.
Crossref
Louis A. Aliperti & Akanksha Mehta. (2016) Peyronie’s Disease: Intralesional Therapy and Surgical Intervention. Current Urology Reports 17:9.
Crossref
Gregory A JoiceArthur L Burnett. (2016) Nonsurgical Interventions for Peyronie's Disease: Update as of 2016. The World Journal of Men's Health 34:2, pages 65.
Crossref
Oliver Kayes & Rauf Khadr. (2016) Recent advances in managing Peyronie’s disease. F1000Research 5, pages 2372.
Crossref
Eric Shaw, Faysal A. Yafi, Premsant Sangkum & Wayne J. G. Hellstrom. 2016. Contemporary Treatment of Erectile Dysfunction. Contemporary Treatment of Erectile Dysfunction
301
313
.
James R. Craig, William O. Brant, James F. Smith & Tom F. Lue. 2016. Contemporary Treatment of Erectile Dysfunction. Contemporary Treatment of Erectile Dysfunction
289
300
.
Carrie A. Stewart, Faysal A. Yafi, Margaret Knoedler, Sree H. Mandava, Ian R. McCaslin, Premsant Sangkum, Suresh Sikka, Landon Trost & Wayne J.G. Hellstrom. (2015) Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location. Journal of Urology 194:6, pages 1704-1707.
Crossref
Kevin K. Yang & Nelson Bennett. (2015) The History of Collagenase Clostridium Histolyticum. Sexual Medicine Reviews 3:4, pages 289-297.
Crossref
F. A. Yafi, M. R. Pinsky, P. Sangkum & W. J.G. Hellstrom. (2015) Therapeutic advances in the treatment of Peyronie's disease. Andrology 3:4, pages 650-660.
Crossref
Ahmed A. Hussein, Amjad Alwaal & Tom F. Lue. (2015) All about Peyronie's disease. Asian Journal of Urology 2:2, pages 70-78.
Crossref
Ahmed A. Hussein, Amjad Alwaal & Tom F. Lue. (2015) WITHDRAWN: All about Peyronie’s disease. Asian Journal of Urology.
Crossref
Giorgio Cavallini. 2015. Peyronie’s Disease. Peyronie’s Disease
85
96
.
Josip Vukina, Aaron C. Lentz, Ryan P. Smith, Larry I. Lipshultz, Culley C. Carson & Robert M. Coward. (2014) Medical Management of Peyronie’s Disease: a 2014 Update. Current Sexual Health Reports 6:3, pages 155-163.
Crossref
Gerald H. Jordan, Culley C. Carson & Larry I. Lipshultz. (2014) Minimally invasive treatment of Peyronie's disease: evidence-based progress. BJU International 114:1, pages 16-24.
Crossref
Ronny B. W. Tan, Premsant Sangkum, Gregory C. Mitchell & Wayne J. G. Hellstrom. (2014) Update on Medical Management of Peyronie’s Disease. Current Urology Reports 15:6.
Crossref
Ashley H. Tapscott & Lawrence S. Hakim. (2013) Office-Based Management of Impotence and Peyronie’s Disease. Urologic Clinics of North America 40:4, pages 521-543.
Crossref
Anthony J. Schaeffer & Arthur L. Burnett. (2013) Nonsurgical Interventions for Peyronie Disease: 2011 Update. Journal of Andrology 33:1, pages 3-14.
Crossref
S M Larsen & L A Levine. (2011) Review of non-surgical treatment options for Peyronie's Disease. International Journal of Impotence Research 24:1, pages 1-10.
Crossref
Gerald H. Jordan & Kurt A. McCammon. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
792
809.e4
.
Ma Limin, Aaron Bernie & Wayne J. G. Hellstrom. 2012. Dupuytren’s Disease and Related Hyperproliferative Disorders. Dupuytren’s Disease and Related Hyperproliferative Disorders
429
437
.
Ege Can Serefoglu & Wayne J. G. Hellstrom. (2011) Treatment of Peyronie’s Disease: 2012 Update. Current Urology Reports 12:6, pages 444-452.
Crossref
Stephen M. Larsen & Laurence A. Levine. (2011) Peyronie’s Disease: Review of Nonsurgical Treatment Options. Urologic Clinics of North America 38:2, pages 195-205.
Crossref
Frederick L. Taylor & Laurence A. Levine. 2011. Cancer and Sexual Health. Cancer and Sexual Health
217
234
.
James F. Smith, William O. Brant & Tom F. Lue. 2011. Contemporary Treatment of Erectile Dysfunction. Contemporary Treatment of Erectile Dysfunction
221
236
.
Alexander Müller & John P. Mulhall. (2009) Peyronie's Disease Intervention Trials: Methodological Challenges and Issues. The Journal of Sexual Medicine 6:3, pages 848-861.
Crossref
J F Smith, T J Walsh & T F Lue. (2008) Peyronie's disease: a critical appraisal of current diagnosis and treatment. International Journal of Impotence Research 20:5, pages 445-459.
Crossref
Yolanda Cockerham & Wayne J.G. Hellstrom. (2008) Nursing practice: a primary care approach to intralesional injection therapy for Peyronies disease. International Journal of Urological Nursing 2:2, pages 78-84.
Crossref
B Fallon. (2007) ‘Off-label’ drug use in sexual medicine treatment. International Journal of Impotence Research 20:2, pages 127-134.
Crossref
Mustafa F. Usta. (2008) Editorial Comment on: Investigation of the Antifibrotic Effect of IFN-γ on Fibroblasts in a Cell Culture Model of Peyronie's Disease. European Urology 53:2, pages 430-431.
Crossref
Simone M. Haag, Ekkehard W. Hauck, Oliver Eickelberg, Carolin Szardening-Kirchner, Thorsten Diemer & Wolfgang Weidner. (2008) Investigation of the Antifibrotic Effect of IFN-γ on Fibroblasts in a Cell Culture Model of Peyronie's Disease. European Urology 53:2, pages 425-431.
Crossref
Frederick L. Taylor & Laurence A. Levine. (2008) Non-surgical therapy of Peyronie's disease. Asian Journal of Andrology 10:1, pages 79-87.
Crossref
Frederick L. Taylor & Laurence A. Levine. (2007) Peyronie's Disease. Urologic Clinics of North America 34:4, pages 517-534.
Crossref
Shane Russell, William Steers & Kevin T. McVary. (2007) Systematic Evidence-Based Analysis of Plaque Injection Therapy for Peyronie's Disease. European Urology 51:3, pages 640-647.
Crossref
Yemi Akin-Olugbade & John P Mulhall. (2007) The medical management of Peyronie's disease. Nature Clinical Practice Urology 4:2, pages 95-103.
Crossref
Muammer Kendirci, Landon Trost & Wayne J. G. Hellstrom. 2007. Peyronie’S Disease. Peyronie’S Disease
81
92
.
Wayne J.G. Hellstrom, Muammer Kendirci, Richard Matern, Yolanda Cockerham, Leann Myers, Suresh C. Sikka, Dennis Venable, Stanton Honig, Andrew McCullough, Lawrence S. Hakim, Ajay Nehra, Lance E. Templeton & Jon L. Pryor. (2006) Single-Blind, Multicenter, Placebo Controlled, Parallel Study to Assess the Safety and Efficacy of Intralesional Interferon α-2b for Minimally Invasive Treatment for Peyronie’s Disease. Journal of Urology 176:1, pages 394-398.
Crossref
Ekkehard W. Hauck, Thorsten Diemer, Hans U. Schmelz & Wolfgang Weidner. (2006) A Critical Analysis of Nonsurgical Treatment of Peyronie’s Disease. European Urology 49:6, pages 987-997.
Crossref
Tansel Inal, Zafer Tokatli, Murat Akand, Erol Özdiler & Önder Yaman. (2006) Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie’s disease: A randomized and prospective study. Urology 67:5, pages 1038-1042.
Crossref
John J. MulcahyJ. Slade Hubbard & Culley C. Carson. 2006. Male Sexual Function. Male Sexual Function
381
399
.
Ajay Nehra & John Mulhall. 2006. Standard Practice in Sexual Medicine. Standard Practice in Sexual Medicine
158
173
.
J. Dörsam, S. Buse & N. Djakovic. (2005) Die Induratio penis plasticaPeyronie’s disease. Der Urologe.
Crossref
Jason M. Greenfield & Laurence A. Levine. (2005) Peyronie's Disease: Etiology, Epidemiology and Medical Treatment. Urologic Clinics of North America 32:4, pages 469-478.
Crossref
Muammer Kendirci, Mustafa F. Usta, Richard V. Matern, Sepehr Nowfar, Suresh C. Sikka & Wayne J.G. Hellstrom. (2005) The Impact of Intralesional Interferon α‐2b Injection Therapy on Penile Hemodynamics in Men with Peyronie's Disease. The Journal of Sexual Medicine 2:5, pages 709-715.
Crossref
M R Safarinejad. (2004) Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study. International Journal of Impotence Research 16:3, pages 238-243.
Crossref
Dirk Schultheiss, Ralf R Lorenz, Roland Meister, Mareike Westphal, Alexander I Gabouev, Heike Mertsching, Christian Biancosino, Norbert Schlote, Jörg Wefer, Michael Winkler, Christian G Stief & Udo Jonas. (2004) Functional Tissue Engineering of Autologous Tunica Albuginea: A Possible Graft for Peyronie’s Disease Surgery. European Urology 45:6, pages 781-786.
Crossref
Gerald Dang, Richard Matern, Trinity J. Bivalacqua, Suresh Sikka & Wayne J.G. Hellstrom. (2004) Intralesional Interferon-α-2B Injections for the Treatment of Peyronie’s Disease. Southern Medical Journal 97:1, pages 42-46.
Crossref
Mustafa F. Usta & Wayne J.G. Hellstrom. 2004. Male and Female Sexual Dysfunction. Male and Female Sexual Dysfunction
191
202
.
Jacob Rajfer, Nestor Gonzalez-Cadavid & Mark Jalkut. 2004. Atlas of Male Sexual Dysfunction. Atlas of Male Sexual Dysfunction
167
181
.
SHAHRAM S. GHOLAMI, NESTOR F. GONZALEZ-CADAVID, CHING-SHWUN LIN, JACOB RAJFER & TOM F. LUE. (2003) Peyronie’s Disease: A Review. Journal of Urology 169:4, pages 1234-1241.
Crossref
S C Sikka & W J G Hellstrom. (2002) Role of oxidative stress and antioxidants in Peyronie's disease. International Journal of Impotence Research 14:5, pages 353-360.
Crossref
G L LacyIIII, D M Adams & W J G Hellstrom. (2002) Intralesional interferon-alpha-2b for the treatment of Peyronie's disease. International Journal of Impotence Research 14:5, pages 336-339.
Crossref
D. Delavierre, H. Ibrahim & M. Peneau. (2002) Enfermedad de La Peyronie. EMC - Urología 34:1, pages 1-6.
Crossref
Garrett H. Lischer & Ajay Nehra. (2001) New advances in Peyronieʼs disease. Current Opinion in Urology 11:6, pages 631-636.
Crossref
Joseph A. Lasky & Luis A. Ortiz. (2001) Antifibrotic Therapy for the Treatment of Pulmonary Fibrosis. The American Journal of the Medical Sciences 322:4, pages 213-221.
Crossref
M. Brake, H. Loertzer, R. Horsch & H. Keller. (2001) Treatment of Peyronie's disease with local interferon-α 2b. BJU International 87:7, pages 654-657.
Crossref
Shahram S. Gholami & Tom F. Lue. (2001) PEYRONIE'S DISEASE. Urologic Clinics of North America 28:2, pages 377-390.
Crossref
WAYNE J. G. HELLSTROM & TRINITY J. BIVALACQUA. (2013) Peyronie's Disease: Etiology, Medical, and Surgical Therapy. Journal of Andrology 21:3, pages 347-354.
Crossref
SUNIL AHUJA, TRINITY J. BIVALACQUA, JOHN CASE, MARK VINCENT, SURESH C. SJXKA & WAYNE J. G. HELLSTROM. (2013) A Pilot Study Demonstrating Clinical Benefit From Intralesional Interferon Alpha 2B in the Treatment of Peyronie's Disease. Journal of Andrology 20:4, pages 444-448.
Crossref
Süreyya Savaşan, Lisa A. Fulgenzi, Raja Rabah, Anwar N. Mohamed & Yaddanapudi Ravindranath. (1998) Generalized infantile myofibromatosis in a patient with Turner’s syndrome: A trial of interferon-α. The Journal of Pediatrics 133:5, pages 694-696.
Crossref
Jamil Rehman, Alexandru Benet & Arnold Melman. (1998) Use of Intralesional Verapamil to Dissolve Peyronie’s Disease Plaque: A Long-Term Single-Blind Study. Urology 51:4, pages 620-626.
Crossref
Ö. Polat, O. Gül, I. Özbey, M. Özdikici & Y. Bayraktar. (1997) Peyronie's disease: Intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging. International Urology and Nephrology 29:4, pages 465-471.
Crossref
M. C. Truss, H.-J. Schäfers, A. J. Becker, S. A. Machtens, M. Sohn, M. Zamani, R. Raab, K. Höfner, C. G. Stief, B. Kulzer, I. Schroeder-Printzen & W. Weidner. 1997. Erektile Dysfunktion. Erektile Dysfunktion
241
323
.
John P. Pryor. 1997. Penile Disorders. Penile Disorders
75
86
.
Laurance A. Levine & Lev Elterman. 1997. Male Infertility and Sexual Dysfunction. Male Infertility and Sexual Dysfunction
474
480
.
H. Koren, G. Alth, G. M. Schenk & R. H. Jindra. (1996) Induratio penis plastica: effectivity of low-dose radiotherapy at different clinical stages. Urological Research 24:4, pages 245-248.
Crossref